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Abstract
Background: Community-associated Clostridium difficile infection (CDI) appears to be an increasing problem. Reported
carriage rates by C.difficile are debatable with suggestions that primary asymptomatic carriage is associated with decreased
risk of subsequent diarrhoea. However, knowledge of potential reservoirs and intestinal carriage rates in the community,
particularly in the elderly, the most susceptible group, is limited. We have determined the presence of C.difficile in the faeces
of a healthy elderly cohort living outside of long-term care facilities (LCFs) in the United Kingdom.
Methods: Faecal samples from 149 community-based healthy elderly volunteers (median age 81 years) were screened for
C.difficile using direct (Brazier’s CCEY) and enrichment (Cooked Meat broth) culture methods and a glutamate dehydrogenase
(GDH) immunoassay. Isolates were PCR-ribotyped and analysed for toxin production and the presence of toxin genes.
Results: Of 149 faecal samples submitted, six (4%) were found to contain C.difficile. One particular sample was positive by
both the GDH immunoassay and direct culture, and concurrently produced two distinct strain types: one toxigenic and the
other non-toxigenic. The other five samples were only positive by enrichment culture method. Overall, four C.difficile
isolates were non-toxigenic (PCR-ribotypes 009, 026 (n = 2) and 039), while three were toxigenic (PCR-ribotypes 003, 005 and
106). All individuals who had a positive culture were symptom-free and none of them had a history of CDI and/or antibiotics
use in the 3 month period preceding recruitment.
Conclusions: To our knowledge, this is the first study of the presence of C.difficile in healthy elderly community-dwelling
individuals residing outside of LCFs. The observed carriage rate is lower than that reported for individuals in LCFs and
interestingly no individual carried the common epidemic strain PCR-ribotype 027 (NAP1/BI). Further follow-up of
asymptomatic carriers in the community, is required to evaluate host susceptibility to CDI and identify dynamic changes in
the host and microbial environment that are associated with pathogenicity.
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Introduction
In the last decade, there has been an upsurge in the prevalence
and severity of Clostridium difficile infection (CDI) such that it has
become a major healthcare problem [1]. This has coincided with
the emergence of more virulent epidemic strains, particularly PCR-
ribotype 027 (NAP1/BI) that have caused hospital outbreaks in
North America and Europe with high morbidity and mortality [2].
There is growing evidence for the existence of significant functional
differences between epidemic and non-epidemic historical types
from isolates of the same ribotype/toxinotype group [3,4], possibly
associated with a strong selective pressure due to broad antimicro-
bial usage. Community-associated CDI appears to be adding to this
disease burden [5], although this may have been underreported.
Relatively little is known about potential community reservoirs
and intestinal carriage rates of C. difficile in individuals living
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outside health care facilities. In neonates, for example, the carriage
frequency is significantly higher than in any adult group [6,7].
Although neonates rarely develop CDI, they may act as important
reservoirs and there is evidence of cross-colonisation amongst
children in day-care facilities, nurseries and kindergartens [7].
Potential sources of C. difficile in the hospital setting include both
symptomatic and asymptomatic patients and contaminated
environments [8]. Riggs et al. [9] suggested that asymptomatic
patients contribute to CDI in long-term care facilities (LCFs), but
it is uncertain whether intestinal carriage by healthy adults in the
community acts as a reservoir and a potential source for
community-associated CDI. Conversely, some authors suggested
that asymptomatic carriage of C. difficile was associated with
decreased risk of subsequent diarrhoea [10], while others believed
that C. difficile was even not part of the normal faecal flora in
elderly in-patients [11].
Carriage and transmission of C. difficile has been studied in the
elderly living in LCFs [12,13], as well as in healthy adults aged up
to 65 years (median age 22 years) in Japan [14,15], many of whom
were University students. Reported asymptomatic carriage rates of
the organism are contentious and vary up to 5-fold across several
studies (4–20%) [9,12–20], in part due to differences in the
population target, such as age, health and dwelling status, as well
as the adoption of different culture and detection standards. To
the best of our knowledge, there are no studies of carriage in
healthy elderly individuals aged 65 years and over residing outside
of LCFs. We have therefore studied the prevalence of asymptom-
atic faecal carriage of C. difficile in a healthy elderly cohort in the
United Kingdom. Isolates were investigated to determine whether
the strains isolated from these individuals were current endemic
PCR-ribotypes and to assess their characteristics and distribution.
Materials and Methods
Ethics Statement: Ethical approval was obtained from the
Liverpool Research Ethics Committee (ref. 08/H1005/32), and
each participant volunteer gave written informed consent.
Two hundred and six members of a large, well studied
longitudinal cohort of healthy elderly volunteers [21] residing in
their own homes in different geographical areas in the north of
England, mostly from Manchester and Newcastle metropolitan
areas [Supporting Information – Figure S1], were approached and
initially agreed to take part of a prospective study of CDI. All
individuals were of white Caucasian origin and were enrolled as
healthy age-matched controls with no clinical evidence of CDI.
A sample collection package was sent to participating volunteers
with accompanying instructions. The package also contained a
questionnaire which included questions about age, gender, a
history of CDI in the preceding year and the details of any
medication taken. Details of acid suppressive agents, including
proton pump inhibitors, and antimicrobial therapy in the
preceding four weeks were specifically requested. Volunteers were
asked to return the stool sample and completed questionnaire by
post to the Medical Microbiology Department in Liverpool. All
samples were collected and received between August and
September 2009.
Faecal samples were assessed according to the Bristol Stool
Chart [22] and cultured for C. difficile by both direct and
enrichment culture methods. Culture was performed with the
faecal sample, either directly or after alcohol-shock treatment, on
Brazier’s cefoxitin-cycloserine egg yolk agar (CCEY, E & O
Laboratories Ltd, Bonnybridge, UK) and then incubated for 48 h
at 37uC in an anaerobic chamber. Similarly enrichment culture
was performed by inoculating the faecal samples into the
enrichment medium processed with and without alcohol-shock
treatment [23]. Cooked meat broth (Oxoid Ltd, Basingstoke, UK)
supplemented (after autoclaving) with sodium taurocholate
(0.05%, Alfa Aesar Ltd, Heysham, UK), lysozyme (5 mg/L,
Sigma-Aldrich, Poole, UK), cycloserine (500 mg/L, Bioconnec-
tions, Wetherby, UK) and cefoxitin (16 mg/L, Bioconnections)
was used as enrichment medium. All positive samples were tested
using a second aliquot from the same submitted specimen to
confirm initial results and multiple colonies selected for PCR-
ribotyping. A faecal sample known to be culture and toxin positive
for C. difficile (ToxA+, ToxB+) was used as a positive control and a
broth inoculated with Escherichia coli ATCC 25922 was used as a
negative control with each batch of specimens cultured. Samples
in enrichment broth were incubated for 48 h at 37uC and then
sub-cultured on to Brazier’s CCEY agar and incubated anaero-
bically for 48 h at 37uC. Potential C. difficile isolates were identified
by their characteristic smell and colonial morphology, fluorescence
under long wave UV light and a latex agglutination test for C.
difficile somatic antigen (Oxoid Ltd, Basingstoke, UK). Isolates
were stored on PROTECT beads (Technical Services Consultants
Ltd, Heywood, UK) at 270uC.
Faecal samples were tested for the presence of both C.difficile
glutamate dehydrogenase (GDH) and toxins A and/or B using C.
DIFF CHEK-60 and TOX A/B II ELISA immunoassay kits
(Techlab, Blacksburg, USA), respectively. Briefly, approximate
100 mg of faeces was mixed with 400 ml of the provided diluent.
The content was then vigorously shaken for 1 minute and
centrifuged at 10,000 g for 1 minute. Supernatants were then
collected and the immunoassay test carried out following the
manufacturer’s instructions. Plates were read at 450 nm and
corrected at 540 nm wavelength.
Stored isolates were sub-cultured for toxin detection and PCR-
ribotyping at a later date. A multiplex PCR assay targeting a
species-specific internal fragment of the triose phosphate isomerase
(tpi) housekeeping gene, internal core sequences of both toxins A
(tcdA) and B (tcdB) genes was used to confirm all isolates as C. difficile
and verify their individual toxigenicity [24]. In addition, all isolates
were tested for toxin expression. The isolate was inoculated into a
15 ml Brain Heart Infusion broth and cooked meat medium
(Southern Group Laboratory Ltd, Corby, UK) and incubated
anaerobically for 18–24 h at 37uC. Cultures were then centrifuged
and the filtered supernatant used to test for the presence of toxins
A and/or B using a TOX A/B II ELISA kit (Techlab, Blacksburg,
USA). Isolates were typed by PCR-ribotyping according to the
method described by Bidet et al [25] and compared to a panel of
the commonest ribotypes circulating in the UK [26].
Results
Faecal samples and questionnaires were received from 149 of
the 206 volunteers approached; 23 declined consent while 34 did
not respond. A summary of demographic information and faecal
culture results is given in Table 1. All individuals in our study were
aged over 70 years (median 81, IQR range, 72–90). The majority
were female (79.9%), which reflects the higher enrolment rates by
female volunteers as well as the presence of significant selective
dropout since these volunteers are part of a large longitudinal
cohort that has been monitored for more than 25 years [21].
Among the individuals recruited, only one reported having CDI
in the previous 12 months; however this individual was not culture
positive for C. difficile. Nine (6%) volunteers had a history of major
gastrointestinal conditions, such as Crohn’s disease, ulcerative
colitis, colectomy/cecotomy and colostomy. At the time of
assessment, 137 of our volunteers (91.9%) were taking medication.
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Thirty-one (21.4%) were taking acid suppressive agents, but only
16 (10.8%) had taken any form of antimicrobial in the four weeks
before providing a sample [Table 1].
All 149 stool samples submitted were considered formed and
none were liquid (type 6 or 7 according to the Bristol stool chart).
One sample was positive for C. difficile by both direct culture and
enrichment culture. Another sample was negative by direct culture
but positive by enrichment culture of the faecal sample treated
with and without alcohol-shock. A further four samples were
positive only by the enrichment culture method without alcohol-
shock treatment [Table 2]. Three isolates were toxigenic (ToxA+,
ToxB+) and four were non-toxigenic (ToxA-, ToxB-) based on our
in vitro assay. No faecal samples were directly positive for Toxin A
and/or B by the ELISA test. Only one of the 149 faecal samples
tested was positive by GDH ELISA; this sample was also positive
by direct culture. The other five samples that were positive by the
enrichment culture method were negative for GDH. Three of
these 6 individuals (50%) with C. difficile carriage were taking acid-
suppressive agents compared to 28/139 (20.1%) of those who were
free of C. difficile (RR=2.48 [95% CI 0.89–4.70], X2= 1.53,
p = 0.22). Conversely, none of these positive subjects had history of
CDI in the past 12 months, and neither did they report use of any
antimicrobials in the previous 3 months prior to the recruitment.
Four out of the seven strains identified in the volunteers were of
non-toxigenic types based on toxin gene screening. PCR-
ribotyping confirmed that the four non-toxigenic isolates had the
following PCR-ribotypes: 009, 026 (n= 2) and 039. Two of them
shared the same ribotype and one volunteer was found to
concurrently carry two distinct strains: PCR-ribotypes 003 and
039 [Supporting Information - Figure S2], the former being
toxigenic. This sample was positive on direct culture and was the
single GDH positive faeces. Further samples were obtained from
this volunteer and showed continued carriage of the strain type
(PCR-ribotype 003) 12 months after the initial sample. No
antibiotics or proton pump inhibitors were used during the one
year follow-up. The other two toxigenic C. difficile strains observed
in our cohort were PCR-ribotypes 005 and 106, which are
amongst the most common strains circulating in the UK [26]. On
further questioning it emerged that the individual carrying PCR-
ribotype 005 worked regularly as a volunteer in a hospital, where
this strain was prevalent.
Discussion
The strength of this study is that it evaluates the presence of C.
difficile in healthy elderly individuals living in the community, from
a very well documented cohort [21]. All individuals were living in
their own homes rather than in a nursing home care facility or in
hospitals and we did not find evidence for geographical location
clustering of positive volunteers. The overall carriage rate of 6/149
(4%) was considerably lower than that of a previous report by
Brazier et al. [17], who found rates of 10.2% for carriage (47/284)
Table 1. Demographic details of the studied subjects and summary of the C.difficile culture results.
PARAMETERS RESULTS N
Age in complete years – Median (IQR) 81 (72–90) 149
Gender – Male vs. Female, n (%) 30 (20.1%) vs. 119 (79.9%) 149
CDI* history in the past 12 months – n (%) 1 (0.7%) 145
Gastro-Intestinal conditions – n (%) 7 (4.7%) 149
Any medications at baseline – n (%) 137 (91.9%) 149
Antibiotics in the last 4 weeks – n (%) 16 (10.8%) 148
PPIs** or anti-acids at baseline – n (%) 31 (21.4%) 145
Carriage of Clostridium difficile – n (%) 6 (4%) 149
*CDI Clostridium difficile infection.
**PPIs Proton pump inhibitors.
doi:10.1371/journal.pone.0022804.t001
Table 2. Summary of C. difficile strains isolated in the study.
No Alcohol Shock Alcohol Shock Multiplex PCR
Sample ID
Direct
Culture
Enrichment
Culture Direct Culture
Enrichment
Culture TPI# Toxin A Toxin B
Toxigenic
culture
GDH1
ELISA
PCR
Ribotype
Sample 1 2 + 2 + + + + + 2 005
Sample 2 2 + 2 2 + + + + 2 106
Sample 3* + + + + + +/2 +/2 +/2 + 003/039
Sample 4 2 + 2 2 + 2 2 2 2 009
Sample 5 2 + 2 2 + 2 2 2 2 026
Sample 6 2 + 2 2 + 2 2 2 2 026
#Triosephosphate isomerase.
1Glutamate Dehydrogenase.
*Sample 3 consistently produced two distinct strains, one toxigenic (ToxA+/ToxB +) and the other non-toxigenic (ToxA2/ToxB2).
doi:10.1371/journal.pone.0022804.t002
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and 6.3% (18/284) for eventual nosocomial acquisition amongst
elderly patients admitted to 6 Welsh hospitals in 1999. In addition,
two studies on healthy adults in Japan by Kato et al. in 2001 [14]
and Ozaki et al. in 2004 [15] reported the presence of C. difficile in
94 of 1,234 subjects (7.6%) and 8 of 139 subjects (5.8%),
respectively. The reported carriage rate with toxigenic strains
were 4% in the two studies, compared with 2% in our study. An
investigation conducted in long-term care facilities in the USA by
Walker [12] found carriage rates of 7.1% in 225 subjects, whereas
another American study [13] reported a rate of 5% (2 in 42
subjects) and a recent Irish investigation observed a prevalence of
asymptomatic C. difficile carriage of 10 in 100 patients (10%), 7 of
which were toxin positive (7%) [20]. These rates are considerably
lower than the carriage rate of 19% reported by Simor et al [16] in
nursing home patients in Canada. It is important to note that, with
exception of the latter study [16], all the above investigations have
used standard direct culture methods only and their figures would
have been higher had they used enrichment culture methods. The
fact we have also identified a sample which produced two distinct
strains also highlights the need for testing multiple colonies isolated
from the same specimen in order to further validate results.
While the Toxin A/B Elisa kit did not identify any positive
samples, only one of the 149 faecal samples tested was positive by
the GDH ELISA test. This sample was also positive by direct
culture and remained culture positive 12 months after the first
sample collection. The other five samples that were positive by
enrichment culture only were negative for GDH. Although GDH
assays reportedly have high specificity to C.difficile [27], it is very
likely that the levels of GDH antigen in these samples were below
the lower detection threshold for this test. Our results suggest that
the GDH assay is significantly less sensitive than enrichment
culture methods and reinforces the importance of enrichment
culture for the screening of solid or semi-solid stools from healthy
volunteers.
We found a range of distinct PCR-ribotypes consistent with the
concept that the population of C. difficile in the community is
significantly more diverse than in LCFs. The fact that two of the
most common toxigenic PCR-ribotypes in the UK (i.e. 005 and
106) were found in our elderly cohort is not surprising. A previous
screening study in Welsh hospitals found that over 50% of the
strains isolated from elderly patients on admission were of PCR-
ribotype 001, which was the most common strain circulating in
hospital settings in the UK at the time [17]. Conversely, the
endemic strain smz, the most frequent type isolated from CDI
patients at that time and known to have caused multiple outbreaks
in Japan, was not found in any healthy carriers by Kato et al. [14].
The epidemic strain type 027/NAP1/BI, which has largely
accounted for the recent upsurge in the number of CDI cases,
and has predominated in hospital settings in the United Kingdom
[26] and Europe was not detected in our community-based elderly
population. Although it is widely acknowledged that the epidemic
PCR-ribotype 027 possesses additional virulence factors, such as
hyperproduction of toxins [2] and increased sporulation rate
[28,29], it remains unclear whether its carriage is less likely to be
asymptomatic in the elderly. Riggs et al. proposed that asymp-
tomatic carriers are a potential source for transmission of epidemic
and non-epidemic strains among LCF residents [9]. While this is
likely to happen in a shared environment, it is uncertain whether
carriage by healthy adults in the community is a potential source
for community-associated CDI, particularly infections accounted
by hypervirulent epidemic strain types, such as PCR-ribotype 027.
It is widely acknowledged that the diversity of C. difficile
population is favoured by the absence of strong selective pressure,
which is a process commonly triggered by antimicrobial agents.
None of the six culture positive individuals gave a history of
antimicrobial treatment in the past four weeks or hospital
admission in the preceding 12 months. Three of the six positive
individuals were receiving acid-suppressive agents. Although this
trend is consistent with the suggestion that these agents facilitate
colonisation by C. difficile [30–32], our study was underpowered to
demonstrate any statistically significant differences given the low
frequency of culture positive samples observed in our cohort.
The frequency and distribution of gastrointestinal carriage of
C.difficile varies across different population groups. Indeed, Kato et
al. found that carriage rates varied across occupational groups,
such as university students, hospital workers, employees of a
company and defence force personnel [14]. Age is another
important predisposing factor. Asymptomatic carriage is higher in
neonates and young infants than in adults, while at the same time,
the distribution of symptomatic CDI cases is much more skewed
towards the elderly. This suggests the existence of biological factors
mediating initial colonisation and onset of the disease and
highlights the importance of investigating both the symptomatic
and asymptomatic carriage of C. difficile in the elderly. This study
confirms that the carriage ratio of C. difficile amongst elderly
individuals residing in their own homes in different geographical
areas is likely to be lower than rates reported for individuals in
LCFs, even after adopting enrichment methods to enhance the
recovery of the organism. Hence, higher rates in LCFs probably
reflect the greater probability of cross-contamination of the
organism in these settings, as well as other contributing factors
such as frailty, polypharmacy and increased use of medicines, such
as proton pump inhibitors and antimicrobials.
Elderly individuals are a difficult group to recruit and one
limitation of our study is the lack of follow-up to distinguish
transient carriage from longer term colonisation. In a single
individual we were able to conduct follow-up and demonstrated
persistent carriage for one year. Another potential source of bias is
the considerably higher rate of females in our cohort. This can
partly be attributed to their greater longevity and to the lower
enrolment and higher dropout rates among males of the original
longitudinal study. The investigation of asymptomatic carriers in
the community is important, not only to assess the host
susceptibility to CDI, but also for the identification of novel
pathogen factors associated with virulence and antimicrobial
resistance. A clearer understanding is needed of why in some
populations, such as neonates and children, C. difficile acts as a
commensal but in others it becomes a pathogen. There is growing
evidence that primary asymptomatic carriage of the organism may
constitute a protective status against subsequent CDI by allowing
the organism to mount an effective immune response. This, for
example, constitutes the basis of recent vaccine trials for
preventing recurrent CDI using multiple doses of non-toxigenic
C.difficile strains as inducers [33]. A prospective investigation of a
cohort of symptom-free C. difficile carriers to ascertain who might
develop symptomatic infection could also help address this
question.
Supporting Information
Figure S1 Geographic distribution of volunteers re-
cruited by this study. A. British Isles; B. Close-up in the
North of England.
(TIF)
Figure S2 PCR-Ribotyping results of the 7 strains
recovered by both direct and enrichment methods. Note
that sample 3 generated isolates of two distinct ribotypes. ‘‘No-
Alcohol’’ indicates no alcohol-shock treatment prior to the culture;
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‘‘Alcohol’’ indicates alcohol-shock treatment prior to the culture
‘‘Enrichment’’ denotes enrichment culture, ‘‘Direct’’ denotes
direct culture.
(TIF)
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